Loading
A phase 3 trial in colorectal cancer, run by Kyungpook National University Hospital, active but no longer recruiting.
Early Commencement of Adjuvant Chemotherapy for Colon Cancer is a phase 3, randomised interventional study registered as NCT01460589 by Kyungpook National University Hospital, with a registry enrolment figure of 303 participants, started 2013-01-13 and due to reach its primary completion in 2024-06-19. Interventions recorded: timing to initiate the adjuvant FOLFOX chemotherapy. Conditions listed: Colon Cancer. Primary outcome: 3-year disease free survival rate. Colorectal eligibility wording from the registry: "* Rectal adenocarcinoma that were 15 cm or more from the anal verge". Sites: South Korea. No results are recorded here; the registry entry is the source.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.